Description
Spexib, also known as Ceritinib 150 Mg Capsules, is a medication used to treat a type of lung cancer called non-small cell lung cancer (NSCLC). This medication is classified as a tyrosine kinase inhibitor and is used to target and inhibit anaplastic lymphoma kinase (ALK) in patients with NSCLC.
Spexib is manufactured by Novartis Pharmaceuticals and is available in 150 mg capsules, with each bottle containing 30 capsules. The medication is meant to be taken orally, with or without food, as directed by a doctor.
At its core, Spexib works by blocking certain proteins that encourage the growth of cancer cells. By doing so, the medication slows down or even stops the growth of tumors, thereby helping to treat NSCLC.
Before taking Spexib, it is important to inform your doctor about any other medications, vitamins, or supplements that you are currently taking. This is because certain medications may interact with Spexib, resulting in unwanted side effects.
It is important to follow the dosage instructions provided by your doctor, as taking too much or too little of the medication may result in unwanted side effects or reduce the effectiveness of the treatment. In addition, it is important to continue taking Spexib even if you feel better, as stopping the medication prematurely may allow cancer cells to continue growing.
Patients taking Spexib may experience side effects, including diarrhea, nausea, vomiting, fatigue, and an increase in liver enzymes. However, if a patient experiences severe side effects or any symptoms of an allergic reaction, they should seek medical attention right away.
In conclusion, Spexib is a valuable medication used to help treat NSCLC. While patients may experience side effects, this medication has been proven effective and is widely used to help improve the quality of life for cancer patients. If you or a loved one has been diagnosed with NSCLC, speak to your doctor to determine if Spexib may be an appropriate treatment option.
Reviews
There are no reviews yet.